Pediatrics:水痘疫苗选择双剂量还是单剂量?

2016-03-28 Seven L MedSci原创

近期发表在Pediatrics的研究称,双剂量水痘疫苗比单剂量更有效。Dana Perella博士和同事对2009-2011年两个监测点诊断为水痘的125名儿童和408名对照组参与者进行了一项病例对照研究,探究双倍剂量水痘疫苗的总体和增量有效性。研究者对接种单剂量水痘疫苗(0-18岁)、双剂量水痘疫苗(4-18岁)的儿童和未接种疫苗的儿童进行了比较。研究数据显示,单剂量水痘疫苗预防水痘的有效性为7

近期发表在Pediatrics的研究称,双剂量水痘疫苗比单剂量更有效。

Dana Perella博士和同事对2009-2011年两个监测点诊断为水痘的125名儿童和408名对照组参与者进行了一项病例对照研究,探究双倍剂量水痘疫苗的总体和增量有效性。研究者对接种单剂量水痘疫苗(0-18岁)、双剂量水痘疫苗(4-18岁)的儿童和未接种疫苗的儿童进行了比较。

研究数据显示,单剂量水痘疫苗预防水痘的有效性为75.6%(95% CI, 38.7-90.3),预防中或重度水痘(至少50处病损)的有效性为78.1%(95% CI, 12.7-94.5)。

双剂量水痘疫苗预防水痘的有效性为93.6% (95% CI, 75.6-98.3),预防中或重度水痘(至少50处病损)的有效性为97.9% (95% CI, 83-99.7)。

对于根据临床表现诊断的水痘,双剂量相比单剂量水痘疫苗,其增量有效性为87.5%;对于实验室检查确诊的水痘,增量有效性为97.3%。

因为有一些突发的水痘案例病损很少,诊断很困难,所有研究者在识别儿童水痘患者时采取了两个标准,一个是根据临床表现和流行病学标准,还有一个则是通过实验室检查确诊。但是数据显示,无论是哪种诊断标准,无论是单剂量还是双剂量水痘疫苗,均表现出了相似的有效性。

Perella和同事写道:“双剂量水痘疫苗表现出了更好的效果,在学校范围内施行双剂量水痘疫苗接种将是非常重要的。对于接种单剂量水痘疫苗的儿童,如果与水痘或带状疱疹患者接触,最好补一针水痘疫苗。”

原始出处:

Perella D, et al. Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.Pediatrics. 2016;doi:10.1542/peds.2015-2802.

Two-dose varicella vaccine more effective than one dose.MedicalXpress.March 28, 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1726063, encodeId=71d51e26063ae, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 05 06:43:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637303, encodeId=8033163e303d5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 04 12:43:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664517, encodeId=ae65166451e2b, content=<a href='/topic/show?id=7ef4642301f' target=_blank style='color:#2F92EE;'>#水痘疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64230, encryptionId=7ef4642301f, topicName=水痘疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Sep 26 11:43:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958463, encodeId=de70195846398, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue May 24 07:43:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78690, encodeId=acd3e869059, content=学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Sat Apr 16 08:13:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478587, encodeId=53dc14e858734, content=<a href='/topic/show?id=73d26422888' target=_blank style='color:#2F92EE;'>#水痘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64228, encryptionId=73d26422888, topicName=水痘)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d957440250, createdName=1249857fm34暂无昵称, createdTime=Wed Mar 30 11:43:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]
    2016-04-05 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1726063, encodeId=71d51e26063ae, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 05 06:43:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637303, encodeId=8033163e303d5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 04 12:43:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664517, encodeId=ae65166451e2b, content=<a href='/topic/show?id=7ef4642301f' target=_blank style='color:#2F92EE;'>#水痘疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64230, encryptionId=7ef4642301f, topicName=水痘疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Sep 26 11:43:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958463, encodeId=de70195846398, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue May 24 07:43:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78690, encodeId=acd3e869059, content=学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Sat Apr 16 08:13:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478587, encodeId=53dc14e858734, content=<a href='/topic/show?id=73d26422888' target=_blank style='color:#2F92EE;'>#水痘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64228, encryptionId=73d26422888, topicName=水痘)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d957440250, createdName=1249857fm34暂无昵称, createdTime=Wed Mar 30 11:43:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1726063, encodeId=71d51e26063ae, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 05 06:43:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637303, encodeId=8033163e303d5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 04 12:43:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664517, encodeId=ae65166451e2b, content=<a href='/topic/show?id=7ef4642301f' target=_blank style='color:#2F92EE;'>#水痘疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64230, encryptionId=7ef4642301f, topicName=水痘疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Sep 26 11:43:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958463, encodeId=de70195846398, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue May 24 07:43:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78690, encodeId=acd3e869059, content=学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Sat Apr 16 08:13:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478587, encodeId=53dc14e858734, content=<a href='/topic/show?id=73d26422888' target=_blank style='color:#2F92EE;'>#水痘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64228, encryptionId=73d26422888, topicName=水痘)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d957440250, createdName=1249857fm34暂无昵称, createdTime=Wed Mar 30 11:43:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1726063, encodeId=71d51e26063ae, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 05 06:43:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637303, encodeId=8033163e303d5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 04 12:43:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664517, encodeId=ae65166451e2b, content=<a href='/topic/show?id=7ef4642301f' target=_blank style='color:#2F92EE;'>#水痘疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64230, encryptionId=7ef4642301f, topicName=水痘疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Sep 26 11:43:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958463, encodeId=de70195846398, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue May 24 07:43:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78690, encodeId=acd3e869059, content=学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Sat Apr 16 08:13:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478587, encodeId=53dc14e858734, content=<a href='/topic/show?id=73d26422888' target=_blank style='color:#2F92EE;'>#水痘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64228, encryptionId=73d26422888, topicName=水痘)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d957440250, createdName=1249857fm34暂无昵称, createdTime=Wed Mar 30 11:43:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]
    2016-05-24 hbwxf
  5. [GetPortalCommentsPageByObjectIdResponse(id=1726063, encodeId=71d51e26063ae, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 05 06:43:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637303, encodeId=8033163e303d5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 04 12:43:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664517, encodeId=ae65166451e2b, content=<a href='/topic/show?id=7ef4642301f' target=_blank style='color:#2F92EE;'>#水痘疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64230, encryptionId=7ef4642301f, topicName=水痘疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Sep 26 11:43:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958463, encodeId=de70195846398, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue May 24 07:43:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78690, encodeId=acd3e869059, content=学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Sat Apr 16 08:13:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478587, encodeId=53dc14e858734, content=<a href='/topic/show?id=73d26422888' target=_blank style='color:#2F92EE;'>#水痘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64228, encryptionId=73d26422888, topicName=水痘)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d957440250, createdName=1249857fm34暂无昵称, createdTime=Wed Mar 30 11:43:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]
    2016-04-16 田田1746

    学习知识

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1726063, encodeId=71d51e26063ae, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 05 06:43:00 CST 2016, time=2016-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637303, encodeId=8033163e303d5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Dec 04 12:43:00 CST 2016, time=2016-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664517, encodeId=ae65166451e2b, content=<a href='/topic/show?id=7ef4642301f' target=_blank style='color:#2F92EE;'>#水痘疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64230, encryptionId=7ef4642301f, topicName=水痘疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Sep 26 11:43:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958463, encodeId=de70195846398, content=<a href='/topic/show?id=766713993a1' target=_blank style='color:#2F92EE;'>#Pediatric#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13993, encryptionId=766713993a1, topicName=Pediatric)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue May 24 07:43:00 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78690, encodeId=acd3e869059, content=学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Sat Apr 16 08:13:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478587, encodeId=53dc14e858734, content=<a href='/topic/show?id=73d26422888' target=_blank style='color:#2F92EE;'>#水痘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64228, encryptionId=73d26422888, topicName=水痘)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d957440250, createdName=1249857fm34暂无昵称, createdTime=Wed Mar 30 11:43:00 CST 2016, time=2016-03-30, status=1, ipAttribution=)]

相关资讯

世卫组织回应中国疫苗事件:等待调查结果公布

世界卫生组织了解到中国近日的疫苗事件,报道称一家庭购买疫苗并转售给医院和接种点。中国政府正积极调查此案,调查结果将在数日后公布。 世卫组织将等待调查结果的公布,时刻准备为国家卫生部门提供支持。疫苗应该正确储存和管理,否则将失去效力或降低效力。 但必须注意的是,不正确储存或过期的疫苗几乎不会引起毒性反应,因此在本事件中,疫苗安全风险非常低。儿童面临的风险在于缺乏对

疫苗危机后的科学反思

5.7亿元的涉案金额,18个省份的波及范围,25种问题疫苗在列……近日,山东警方破获的非法经营疫苗案,让公众大跌眼镜,不安、恐慌的情绪逐渐蔓延。 面对网络上充斥的“毒疫苗”“杀人疫苗”“夺命疫苗”等字眼,一位两岁孩子的母亲用“心惊肉跳”形容自己的感受。一篇2013年的旧文《疫苗之殇》在朋友圈的广泛传播,在混淆“疫苗不良反应”与“不良疫苗反应”概念的同时,也令公众的恐慌情绪进一步升级。

血样中成功发现肺结核生物标记物!

世界上三分之一的人口被认为感染了结核分枝杆菌,一种能引发肺结核的细菌,但是仅仅一小部分人曾出现有症状的疾病。如今,一个国际研究小组已经在潜伏感染人群的血液中鉴定出生物标记物,这给医生们提供了一种他们长期寻找的工具:一种预测谁正处于感染活性肺结核疾病风险的方法。如果通过其他临床试验得以确证,一种基于这些血液标记物的测试将使得医生能够针对高风险人群予以治疗,从而预防他们患病。

世卫组织回复关于中国疫苗事件中的疑问

世界卫生组织就中国疫苗事件中网民提到的问题进行了收集,并将回复整理如下: 1中国的一类和二类疫苗有什么区别? 一类疫苗是政府扩大免疫规划使用的疫苗,使儿童能预防12种传染病。一类疫苗免费向中国儿童提供,也是儿童必须接种的疫苗。二类疫苗是父母自主选择为儿童补充接种的疫苗,例如可预防B型流感嗜血杆菌所致疾病、侵袭性肺炎链球菌病和轮状病毒胃肠炎。接种二类疫苗需